Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
about
Novel targets for interleukin 18 binding proteinA complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity.The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta.Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18The IL-1 cytokine family and its role in inflammation and fibrosis in the lungStructural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responsesThe structure and binding mode of interleukin-18Unusual Water-mediated Antigenic Recognition of the Proinflammatory Cytokine Interleukin-18Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding proteinStructural insights into the assembly and activation of IL-1β with its receptorsInterleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferationPathophysiological roles for IL-18 in inflammatory arthritisMycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanismIL1R9 Is Evolutionarily Related to IL18BP and May Function as an IL-18 Receptor.Interleukin-18.Targeting interleukin 18 with interleukin 18 binding protein.Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.Identification of small molecule inhibitors of Interleukin-18.Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.Tumor necrosis factor-alpha causes release of cytosolic interleukin-18 from human neutrophils.Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease.Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein AInterleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins.Interleukin 18 in the CNS.Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte deathInterleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activationIL-27 Regulates IL-18 binding protein in skin resident cellsThe interleukin-1 family: back to the futureSurvey of the year 2000 commercial optical biosensor literature.Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1betaSite-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein.Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa.Identification of constitutively active interleukin 33 (IL-33) splice variant.Increased expression of IL-18 in the serum and islets of type 1 diabetics.Effects of statins on TH1 modulating cytokines in human subjects.Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destructionInterleukin-18 and host defense against infection.Disruption of interleukin-18, but not interleukin-1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammationIncreased circulating interleukin-18 in patients with congestive heart failure.
P2860
Q24292449-F8276FAA-C36B-4B3E-9361-6C685E277C64Q24536244-5DD58687-3077-4352-9D59-CFC2DC8BE511Q24544009-19536108-A324-4D26-A769-CDA46B18AA29Q24657195-83E409DB-7DA5-45B3-96C5-6569842A0EDAQ26752849-8F3079F5-7BA1-446B-9CD0-2763A3089A47Q26992101-5C52A3AD-162B-439D-98F6-21846E226510Q27642289-A5789AA7-1220-49E5-88F6-A223A729FAF3Q27646272-109CDF54-74BE-4FC7-9BDD-49D8969BDC23Q27653252-0CEEDB0D-6CD7-47BA-A1EC-74C15617717EQ27664215-1F3A1E81-503F-4379-91D4-17ED94E7189AQ28118491-8B86E375-EEB6-4DE5-8642-2D5B33E27830Q28187644-194DD3B7-DD32-46B3-9C85-4213CAE5758EQ28469036-613C8671-8267-4C33-B539-D1D348614799Q30395586-B02B6472-08B9-43B9-984A-5B3BA698B64EQ30884172-DB84CA81-A9E8-47AE-81E8-277DF44652D5Q30951696-80E99F93-2A9D-402E-8CA1-C939A3E458B9Q33507170-46AF7D94-9CF6-4485-BAE2-968FADAC64B8Q33673256-9C718B73-38DB-4C39-B46C-72C77D5B1C10Q33689422-AF94F146-C580-4711-A11F-77D7A568D78DQ33727625-5A868152-686E-4616-82F9-4E86A81C1879Q33750037-6E7F910C-BE72-44A0-BFB3-EC790B734CC9Q33793186-92B92AE3-635C-4D81-A3A1-AE0180791381Q33801215-5CCB4649-1634-4A78-A11A-2EF88135DD8CQ33847066-3C90311B-AE39-4D74-991F-8630F68698D7Q34095673-F82547F8-5E02-4E13-A7A2-32A602894DFEQ34150569-7F12D683-994E-4E03-BDF3-32E5F3193520Q34212169-885DCB56-24D5-47CB-A889-BC503DEAEFA9Q34325776-C0900164-9298-46F9-8A31-6F5DE6FA1A31Q34391415-4A6562BC-B005-435E-9681-0282CE60D9BEQ34464911-2DEAE275-7A21-4582-990E-9EA6198B4EEBQ34501732-142BE58A-93C4-46F5-9DB1-40D690D45B51Q34724669-FF4816D0-8F98-48CF-BA7F-E054995C0149Q34851368-4D02BCD5-6290-487A-859A-4AF719CB1BE7Q35011144-1C42B4A0-DDEE-4A06-A593-A89290038DCCQ35044541-EC4A0B24-A5C2-4287-86A3-04CFF231DB3BQ35081825-DF4F6DD6-D9C5-49DC-9F7E-960CF2309A32Q35103096-1C62DD24-1853-49E2-8339-1A9DE44E626FQ35147841-C906DF30-AF9C-4229-B751-131AC744813BQ35222066-2EB7E6A0-1B87-46D3-B744-F3B2011D27C1Q35580387-84C466DC-6C6A-4A1B-A372-6CF88A4E8F0D
P2860
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Structural requirements of six ...... nding protein to inhibit IL-18
@ast
Structural requirements of six ...... nding protein to inhibit IL-18
@en
Structural requirements of six ...... nding protein to inhibit IL-18
@nl
type
label
Structural requirements of six ...... nding protein to inhibit IL-18
@ast
Structural requirements of six ...... nding protein to inhibit IL-18
@en
Structural requirements of six ...... nding protein to inhibit IL-18
@nl
prefLabel
Structural requirements of six ...... nding protein to inhibit IL-18
@ast
Structural requirements of six ...... nding protein to inhibit IL-18
@en
Structural requirements of six ...... nding protein to inhibit IL-18
@nl
P2093
P2860
P50
P3181
P356
P1476
Structural requirements of six ...... nding protein to inhibit IL-18
@en
P2093
C A Dinarello
L Reznikov
M Eisenstein
P2860
P304
P3181
P356
10.1073/PNAS.97.3.1190
P407
P577
2000-02-01T00:00:00Z